Descriptor: "Campath (Medication) -- Evaluation -- Product/service Evaluations" / Publisher: newsrx llc - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Campath (Medication) -- Evaluation -- Product/service Evaluations"' showing total 3 results

Start Over Descriptor "Campath (Medication) -- Evaluation -- Product/service Evaluations" Publisher newsrx llc

Subjects: MabThera (Medication) -- Evaluation -- Product/service Evaluations, Campath (Medication) -- Evaluation -- Product/service Evaluations, Drug therapy, Evaluation, Complications and side effects, Non-Hodgkin lymphomas -- Drug therapy -- Complications and side effects, AIDS (Disease) -- Complications and side effects -- Drug therapy, Non-Hodgkin's lymphomas -- Drug therapy -- Complications and side effects
Abstract: 2003 FEB 11 - (NewsRx.com & NewsRx.net) -- 'Rituximab (Mabthera) and alemtuzumab (Campath, Mabcampath) are non-conjugated IgG1 therapeutic monoclonal antibodies directed against the CD20 and CD52 surface antigens respectively. They [...]
Published: 2003

Subjects: Chronic lymphocytic leukemia -- Drug therapy, Business, Health, Health care industry, Campath (Medication) -- Evaluation -- Product/service Evaluations
Abstract: 2003 JAN 14 - (NewsRx.com & NewsRx.net) -- Findings obtained from a compassionate use study of the humanized monoclonal antibody alemtuzumab (Campath/MabCampath) in patients with refractory B-cell chronic lymphocytic leukemia [...]
Published: 2003

Subjects: Chronic lymphocytic leukemia -- Drug therapy, Business, Health, Health care industry, Campath (Medication) -- Evaluation -- Product/service Evaluations, Fludara (Medication) -- Evaluation -- Product/service Evaluations
Abstract: 2003 JAN 14 - (NewsRx.com & NewsRx.net) -- Efficacy and safety data from an ongoing phase II clinical trial of combination fludarabine phosphate (Fludara) and alemtuzumab (Campath/MabCampath) therapy (FluCam) for [...]
Published: 2003

Books, media, physical & digital resources

Searchworks